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Increasing efforts to identify alternate expressions of neuropsychiatric disorders that are broader than the DSM or ICD diagnostic 
criteria needed to diagnose them reflects a growing consensus that multidimensional expressions of neuropsychiatric disorders 
may advance the search for underlying etiological or modulatory factors. Endophenotypic research can be considered to be one of 
the most promising strategies to bridge the gap between genomic complexity and the phenotypic heterogeneity observed in neu-
ropsychiatric disorders. However, the majority of endophenotype studies were limited to our western counterparts, very little has 
been done and initiated by scholars in mainland China. In this paper, we urge the need to establish a potential central consortium 
for endophenotypes to study neuropsychiatric disorders in mainland China. In particular, we illustrate a potential example of neu-
rological soft signs in following the steps for building the consortium. 
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This strategic paper argues the need for establishing a cen-
tral consortium for the endophenotype approach for neuro-
psychiatric disorders in mainland China. We start with a 
brief introduction to endophenotypes, what is known about 
the concept of endophenotypes, and then to illustrate the 
claim that endophenotypes are more important than tradi-
tional genetic approach of studying neuropsychiatric disor-
ders. This is not our intention to provide a comprehensive 
review of all endophenotypes employed in neuropsychiatric 
disorders in this strategic paper because there are several 
systematic reviews on this aspect [1–4]. However, we 
would illustrate an example of a promising endophenotype, 
neurological soft signs, in detailing the steps for building 
the consortium. 
1  The concept of endophenotype 
The term “endophenotype” was firstly coined by John and 
Lewis [5] who used it to explain concepts in evolution and 
inset biology. The Greek word “endos” means interior and 
within. By that time, John and Lewis attributed the geo-
graphical distribution of grasshoppers was a function of 
some feature not apparent in their “exophenotypes”, and 
this feature was “the endophenotype, not the obvious and 
external but the microscopic and internal”. Gottesman and 
Shields [6,7] then adapted this term to specifically link glu-
cose tolerance test as an endophenotype that are heritable 
biomarkers not observed by the naked eye. According to 
this new definition, Gottesman and Shields intended to link 
this glucose tolerance test as an endophenotype for diabetes. 
The term, endophenotype, however, is also very useful to 
suit the needs of psychiatric genetics, and to fill the gap 
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between available descriptors and between the gene and the 
elusive disease processes. Endophenotypes in psychiatry 
nowadays retain the notion of an internal process that can-
not be observed with naked eyes but can be objectively and 
reliably measured.  
Despite the inherent advantages and innovation of the 
concept postulated by Gottesman and Shields, endopheno-
types have been received relatively attention as compared to 
genetic approach. However, as more and more evidence 
coming from genetic studies have proven unsuccessful, the 
merits of endophenotypes outstanding the conventional ge-
netic approach in neuropsychiatric disorders research more 
clearly [6,7]. First, the uncertain and phenomenological 
nature of psychiatric diagnosis makes reference to a biolog-
ical level of description attractive. Second, the complexity 
of the human brain obviously necessitates an effort to parse 
this problem into tractable biological subprocesses [2]. 
2  Advantages of endophenotypes strategy for 
neuropsychiatric disorders research 
Despite the fact that genetic contributions to complex neu-
ropsychiatric disorders such as schizophrenia and bipolar 
disorders are well-accepted [8–10], the identity of most 
genes that increase susceptibility to the disorders, and the 
biological mechanism by which they act, are still largely 
unknown. The completion of human genome sequencing 
does not mean we can grasp a more comprehensive view 
about the etiologies of these complicated neuropsychiatric 
disorders since the study of these disorders is complicated 
by the polymorphisms of the diseases, impact of environ-
ment as well as interaction between genes and environment 
[11,12]. Conventional genetic approach has shown an un-
successful outcome evidenced by the unreplicated findings 
and unrealized expectations. Given that endophenotypes 
represent more defined and quantifiable measures that are 
envisioned to involve fewer genes, fewer interacting levels 
and ultimately activation of a single set of neuronal circuits, 
they are potentially more tractable to genetic dissection than 
the mental disease states [2]. It provides a very good alter-
native method to study the etiologies of complex polymor-
phism neuropsychiatric disorders. 
The application of endophenotype approach reserves a 
number of merits to study neuropsychiatric disorders as 
compared to the conventional genetic approach such as the 
neural-based endophenotypes may more directly reflect the 
activities of synaptic and other neuronal mechanisms than 
does the more complex illness itself; the endophenotypes 
can also be investigated via brain-imaging and infrahuman 
animal model research [1,4,13]. Moreover, many risk gene 
associations to brain-based phenotypes can also be observed 
in healthy individuals suggesting that this approach offers a 
very powerful bottom-up strategy to discover biologically 
valid knowledge about previously unknown mechanisms 
[14]. 
3  Criteria and clinical steps for endophenotypes 
research 
There are several stringent criteria to be fulfilled for being 
an endophenotype for a particular neuropsychiatric disorder 
such as schizophrenia and bipolar disorders. To name briefly, 
these are association with the illness, be heritable, be pri-
marily state independent, and co-segregate within families 
and can be reliably measured [1,2,15]. Recently, the Con-
sortium on the Genetics of Schizophrenia (COGS) funded 
by the National Institute of Mental Health (NIMH) has re-
fined and extended the criteria for endophenotypes [4,16, 
17]. The selection of the neurocognitive measures for 
COGS is listed below:  
(1) Association with illness is specifically referring to 
moderate to large effect sizes between schizophrenia pa-
tients and community controls. 
(2) State independent is further divided into detailed 
psychometric properties of the measure itself over a period 
of time (adequate test-retest stability) and reliability be-
tween among different sites (adequate between-site reliabil-
ity). Moreover, strong evidence has to be gained for the 
observed impairments in patients are not due to medications, 
including direct comparisons between medicated vs. un-
medicated patients, medication-naive vs. medicated patients, 
and correlations between performance and medications; 
evidence that impairments are observed regardless of the 
illness state, including that first-episode, chronic, and re-
mitted patients exhibit similar patterns of impairments.  
(3) Heritability of the endophenotypes is further divided 
into the heritability in healthy populations and in schizo-
phrenia families.  
(4) Found in unaffected relatives at a higher rate than in 
the general population so that small to moderate effect sizes 
between biological relatives of schizophrenia patients and 
community controls are observed.  
(5) The elected measures should have a known neurobi-
ological substrate relevant to schizophrenia and whose ini-
tial results support using them to test genetic hypotheses.  
(6) The practicality of task administration in a large mul-
tisite protocol. 
Braff et al. [13] further delineate a systematic procedure 
for researchers to adopt the endophenotype strategy for 
neuropsychiatric disorders research. These are (1) clinical 
observation that gives rise to the prevalence of specific in-
dicators in the clinical group as compared to healthy con-
trols; (2) quantifiable measurement based on laboratory 
findings or related neuropsychological tests to demonstrate 
the magnitude of deficits; (3) heritability and genetic studies 
to identify any familial-transmitted traits; (4) modeling of 
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brain imaging to clarify the neural basis of the trait, and 
specific molecular variations identified from family and 
association studies; and (5) drug development as the ulti-
mate outcome. 
4  The Consortium on Human Information and  
Neurocognitive Endophenotypes (CHINE)  
Here we argue the need to set up a nation-wide database for 
neuropsychiatric disorders, namely the Consortium on Hu-
man Information and Neurocognitive Endophenotypes 
(CHINE) [18]. The CHINE is intentionally established to 
follow the roadmap of the NIMH on the identification of the 
biosignatures for neuropsychiatric disorders and to serve as 
the central databank for examining the etiologies of major 
complex neuropsychiatric disorders as well as serving the 
main basis for corresponding treatment development. The 
CHINE emphasizes on two main features, i.e., the suppos-
edly universal basic cognitive functioning such as attention, 
and the supposedly culturally specific social cognitive func-
tioning such as emotion perception and expression. In this 
consortium, we are going to collect data at three main levels 
highlighting the genetic level (susceptibility genes associat-
ing with major neuropsychiatric disorders such as schizo-
phrenia, bipolar disorders, ADHD etc.), neuroanatomical 
level (structural and functional imaging data), behavioural 
level (neurocognitive function performances, social cogni-
tive functioning, neurological and clinical manifestations). 
Target groups include both the clinically diagnosed patients 
suffering from neuropsychiatric disorders (mainly schizo-
phrenia and bipolar disorders at the current moment, but 
will be extended to other clinical groups later), non-psychotic 
first-degree relatives of the patients, and healthy controls.  
Here we would like to illustrate the structure of this con-
sortium with an example from neurological soft signs. Chan 
and Gottesman [19] have systematically provided substan-
tial evidence to support the candidature of neurological soft 
signs as potential endophenotypes for schizophrenia [2,6,13]. 
Figure 1 illustrates the neurological soft signs and other 
related neurocognitive functions are the crucial indicators to 
bridge the gap between the microscopic level of genomics 
and brain structures and the macroscopic level of clinical 
manifestations in understanding the etiology of schizophrenia.  
Figure 2 illustrates how neurological soft signs database 
fits into the logic of these steps. It should be noted that the 
final step for drug development will take quite a lot of time 
to be achieved. We will base our opinion on this database 
we have established in China and the existing literature 
from western studies to illustrate such a claim. 
5  Illustration of neurological soft signs as an 
example from CHINE 
(i) Step 1: Clinical observation.  The prevalence rate of 
neurological signs among patients with schizophrenia rang-
es from 50% to 65% in contrast to 5% in healthy controls in 
western samples [20,21]. However, specifically for soft 
signs, the prevalence rate ranges from 9% to 82% as com-
pared to 3% to 12.5% [22–29]. The only available data for 
Chinese patients with schizophrenia and healthy controls 
reveals that the prevalence rates in Chinese patients with 
schizophrenia and healthy controls are 59% and less than 
5%, respectively [30]. 
Our Chinese database indicates the prevalence rate of 
soft signs in unaffected first-degree relatives of schizophrenia 
ranges from 5% to 66% [31]. The meta-analysis from our  
 
Figure 1  Endophenotypes serve as the intermediate layer to bridge the gap between phenotypic and genomic knowledge bases of schizophrenia. Cognitive 
phenotypes: SA, sustained attention; WM, working memory; VM, verbal memory; IC, inhibitory control. Neurological soft signs: MC, motor coordination; 
SI, sensory integration; DIS, disinhibition. 
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Figure 2  Five steps of endophenotype strategy for building up the neurological soft signs database in schizophrenia.  
laboratory suggests that the effect size of the prevalence for 
nonpsychotic siblings of patients with schizophrenia com-
pared to their affected siblings and healthy controls was 
0.75 and 0.95, respectively [32]. Another meta-analysis [33] 
also shows that there are large effect sizes of deficits (Co-
hen’s d) found in patients with chronic schizophrenia and 
first-episode schizophrenia contrasted with normal controls. 
The effect sizes of motor coordination signs, sensory inte-
gration signs, and complex motor sequencing signs in 
chronic patients are 0.86, 0.88, 0.80, respectively, whereas 
those for the first-episode patients are 1.020, 0.84, and 0.78, 
respectively. Specifically to the Chinese samples, the effect 
sizes of motor coordination signs, sensory integration signs, 
and disinhibition signs in chronic patients are 0.94, 0.56, 
and 0.99, respectively. Moreover, similar deficits of neuro-
logical soft signs have also been found in nonpsychotic 
family members of schizophrenia, with the magnitudes of 
deficits intermediate between patients and healthy controls. 
The effect sizes of motor coordination, sensory integration 
and complex motor sequencing between patients and nonpsy-
chotic family members are 0.83, 0.34, and 0.61, respectively, 
whereas those between nonpsychotic family members and 
healthy controls are 0.31, 0.32, and 0.14, respectively [32].  
(ii) Step 2: Quantifiable measurement.  The standardi-
zation of a measuring tool is the essential step to proof for 
its reliability and validity in measuring the construct we are 
intending to do. Although neurological soft signs were con-
ventionally considered to be the signs induced by non-local-     
izing brain regions, most recent findings demonstrate that 
these signs can be measured reliably and validly [34,35]. 
Moreover, some also suggest there will be a localized spe-
cific pathway or connection instead of a diffused brain re-
gions involvement (c.f. modeling of organism and brain 
imaging section below). Our database also suggests that, at 
the conceptual and construct levels, neurological soft signs 
are more or less capturing the same construct measured by 
traditional neurocognitive tests using the structural equation 
modeling approach [36]. All the neurological soft signs 
subscales such as motor coordination, sensory integration, 
and disinhibition were significantly correlated with execu-
tive function, verbal memory, and visual memory. The same 
model were demonstrated in two independent samples of 
schizophrenia and healthy volunteers, suggesting that neu-
rological soft signs and conventional neurocognitive func-
tioning tests are capturing the same underlying deficits of 
brain functions in schizophrenia.  
(iii) Step 3: Heritability and genetic mapping.  Existing 
literature from the western sample suggest that portion of 
the neurological soft signs, particularly the motor coordina-
tion and complex motor sequencing tasks are highly herita-
ble, e.g., rapid alternating movement (h2 0.99±0.19 for 
completion time), go-nogo task (h2 0.93±0.33 for correct 
responses), alternating fist-palm test (h2 0.77±0.19 for com-
pletion time; h2 0.7±0.32 for errors), and fist-ring test (h2 
0.53±0.23 for right-sided completion time; h2 0.7±0.21 for 
left-sided completion time). However, Braff et al. [13] em-
phasize that the endophenotype strategy is to find out not 
only a heritable trait or marker but also a “mappable” one 
linking to genetic basis. They have illustrated this point with 
their COGS project by referring the mappability of P50 
suppression to SNPs in the promoter region of the alpha-7 
nicotinic receptor [37] and its potential development and 
initial clinical trials of alpha-7 nicotinic agonists for the 
treatment of schizophrenia [38]. 
For neurological soft signs, twins data from limited 
western samples suggest that schizophrenia and neurological 
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soft signs share genetic influences but indicate that the ge-
netic overlap between schizophrenia and neurological soft 
signs is not very substantial [39–41]. However, these find-
ings might have been limited by the small number of twin 
studies and the corresponding small sample sizes. Our pre-
liminary findings from a total of 250 healthy twins data 
suggest that the heritability of motor coordination, sensory 
integration, disinhibition subscores, and the total score of 
neurological soft signs is 0.67, 0.41, 0.41, and 0.75 respec-
tively. However, more data from Chinese familial design 
and clinical twins are needed to further confirm the specific 
heritability of neurological soft signs in schizophrenia. With 
the significant levels of heritability of neurological soft 
signs, at least in motor coordination, we have strong reason 
to believe that mappability and gene discovery will be a 
feasible step to be accomplished in the near future.  
(iv) Step 4: Modelling of organism and brain imaging.  
In order to provide a stronger neural basis of neurological 
soft signs in schizophrenia, our strategy is to leverage these 
signs to conventional neurocognitive functions, the related 
brain structures and connectivity. We hope that we can map 
these signs to genes identified as responsible for aberrant 
brain mechanisms in this clinical group. However, the un-
derlying cerebral changes have not yet been fully identified. 
Limited structural brain imaging from western samples 
suggest that neurological soft signs are associated with en-
largement of cerebral ventricles [42], smaller brain areas 
[43], particularly in grey matter involving in sub-cortical 
regions such as putamen, globus pallidus and thalamus as 
well as cerebellum [44–48]. A similar reduction in grey 
matter volumes in these regions was also demonstrated in 
healthy volunteers [49]. However, a most recent study done 
by Thomann et al. [47] found grey and white matter density 
of distinct brain regions to be significantly associated with 
severity of neurological soft signs in 42 patients with first- 
episode schizophrenia but not healthy controls. In particular, 
the regions involved the pre- and post-central gyrus, pre- 
motor areas, inferior and middle frontal gyri, caudate nu-
cleus, thalamus, and cerebellum.  
Three functional imaging studies found neurological soft 
signs to be associated with sensorimotor cortex changes 
[50–52]. Günther et al. [53] found a bilateral overactivation 
in the precentral gyrus in Type I patients with schizophrenia 
and a decreased activation in Type II patients. Schröder et al. 
[52] demonstrated a decreased activation of sensorimotor 
cortices and SMA, as well as a reversed lateralization effect 
in a group of schizophrenia as compared to the healthy con-
trols using the finger-to-thumb opposition task. Heuser et al. 
[54] further found that there was significantly more varia-
tion in pronation/supination motor coordination task in 
medication naïve schizophrenic patients in addition to a 
diminished sensorimotor cortex and SMA activation. Taken 
together, these findings support the model of cognitive 
dysmetria proposed by Andreasen et al. [55] that strongly 
suggest the resulting disconnection syndrome underlies both 
psychopathological symptoms and neurological abnormali-
ties in schizophrenia.  
On the other hand, similar associations were found with 
decreased activation of the sensorimotor cortices and the 
supplementary motor area using functional neuroimaging 
techniques [54,56]. Most recently, more sophisticated para-
digms using the specific item of motor coordination, namely 
the Fist-Edge-Palm (FEP), have been developed to examine 
underlying neural substrates in healthy volunteers. In the 
FEP task, subject is required to successively place the hand 
in each of the following postures: a fist resting vertically 
(i.e., Fist), a palm resting vertically (i.e., Edge), and a palm 
resting horizontally (i.e., Palm). Umetsu et al. [57] com-
pared right and left hand FEP to relatively simple motor 
tasks, and revealed FEP-induced activation in the multiple 
cortical regions including sensorimotor, premotor, parietal, 
and supplementary motor areas, but not in the prefrontal 
cortex. Chan et al. [58] also replicated FEP-induced activa-
tion in the motor network with no activation in other frontal 
areas. These results are inconsistent with neuropsychologi-
cal testing evidence showing that patients with frontal lobe 
lesions exhibit deficits on the FEP task [59]. A possible 
explanation may be that frontal lobe in FEP is involved in 
integration or regulation of neural activities underlying mo-
tor sequencing rather than being directly activated by FEP. 
However, imaging studies using conventional subtraction 
analyses can only indicate regionally specific effects in the 
context of functional specialization; therefore have no im-
plication to reveal the potential role of prefrontal regions in 
the context of functional integration [60]. A re-analysis of 
these FEP imaging data using psychophysiological interac-
tion (PPI) analysis, however, revealed significantly en-
hanced functional connectivity between the left and right 
sensorimotor cortex and the right inferior and middle frontal 
cortex during the FEP task comparing to a simple motor 
task [61]. These results support the involvement of frontal 
lobe function in FEP and suggest a role of motor regulation 
rather than direct participation of prefrontal cortex in the 
execution of complex motor sequence task such as FEP 
neurological soft signs. However, these findings are limited 
to healthy volunteers and our laboratory is now collecting 
clinical data to examine the activation pattern and connec-
tion in patients with first-episode medication naïve schizo-
phrenia.  
(v) A step beyond: A lifespan perspective of neurological 
soft signs.  As noted above these neurological soft signs 
may not be specific to schizophrenia but also are found in 
other neuropsychiatric disorders such as ADHD [62–64], 
and major depression [65], bipolar disorders [66,67]; there-
fore, the database may be applicable and extended to a wid-
er range of clinical cases with greater public health impact. 
The lifespan database may facilitate us to calculate the 
specificity of neurological soft signs in different stages of 
onset of a specific neuropsychiatric disorder or the corre-
sponding specificity of neurological soft signs in different 
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clinical neuropsychiatric disorders.  
6  Conclusions  
Taken together, the specific information from CHINE on 
neuropsychiatric disorders such as schizophrenia in the 
context of the Chinese setting at the moment confirm neu-
rological soft signs are promising endophenotypes for 
schizophrenia. It is equally notable that the demonstrations 
of neurological soft signs reviewed here represent only a 
few of the potentially important endophenotypes for schiz-
ophrenia in CHINE. Other endophenotypes such as brain 
abnormalities, neural connectivity, cognitive and social 
cognitive functioning as well as the clinical data are equally 
important for the understanding of the neuropsychiatric dis-
orders. The genetic basis of endophenotypes is more tracta-
ble to genetic dissection than that of neuropsychiatric dis-
orders. Finally, it is also noteworthy that the potential trans-
lational usage of neurological soft signs as a quick, quanti-
fiable, sensitive and user-friendly bedside early detection 
and screening tool for clinical practice.  
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